Cumberland Pharmaceuticals Pitch Deck

Financial Overview 19 ($ in millions, except per diluted share) Net Revenues Cost of Products Sold Gross Profit Selling & Marketing Research & Development General Administrative Amortization Operating Income (Loss) Adjusted Earnings* per diluted share *Represents a non-GAAP financial measure. YTD 2019 $33.9 6.0 $27.9 $15.8 4.0 7.6 3.1 ($2.6) $0.22

View entire presentation